Matches in SemOpenAlex for { <https://semopenalex.org/work/W2281780212> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2281780212 endingPage "31" @default.
- W2281780212 startingPage "627" @default.
- W2281780212 abstract "To explore the efficacy and side effects of icotinib hydrochloride in the treatment of patients with advanced non-small cell lung cancer (NSCLC).The efficacy and side effects of icotinib hydrochloride in treatment of 59 cases with stage IV NSCIC and followed-up from March 2009 to January 2012 were retrospectively analyzed.Twenty seven patients (45.8%) showed partial response (PR), 17 patients (28.8%) achieved SD, and 15 (25.4%) had progressive disease. The objective response rate (ORR) was 45.8% (27/59), and disease control rate (DCR) was 74.6% (44/59). Among the 23 patients with EGFR mutation, ORR was 73.9% (17/23), and DCR was 95.7% (22/23). Thirty six patients (61.0%) achieved remission of symptoms to varying degrees. The main symptoms relieved were cough, asthmatic suffocating, pain and hoarseness. The major adverse events were mild skin rash (35.6%) and diarrhea (15.3%). Others were dry skin, nausea and stomach problems. The efficacy of icotinib hydrochloride were related to the ECOG performance status, smoking history, EGFR mutation and rash significantly (P < 0.05).Monotherapy with icotinib hydrochloride is effective and tolerable for patients with advanced NSCLC, especially with EGFR mutation." @default.
- W2281780212 created "2016-06-24" @default.
- W2281780212 creator A5003759585 @default.
- W2281780212 creator A5005320470 @default.
- W2281780212 creator A5006794153 @default.
- W2281780212 creator A5012989533 @default.
- W2281780212 creator A5034024641 @default.
- W2281780212 creator A5056078581 @default.
- W2281780212 creator A5060962854 @default.
- W2281780212 creator A5064287277 @default.
- W2281780212 creator A5067484188 @default.
- W2281780212 date "2012-08-01" @default.
- W2281780212 modified "2023-10-18" @default.
- W2281780212 title "[Clinical observation of icotinib hydrochloride for patients with advanced non-small cell lung cancer]." @default.
- W2281780212 doi "https://doi.org/10.3760/cma.j.issn.0253-3766.2012.08.016" @default.
- W2281780212 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23159001" @default.
- W2281780212 hasPublicationYear "2012" @default.
- W2281780212 type Work @default.
- W2281780212 sameAs 2281780212 @default.
- W2281780212 citedByCount "9" @default.
- W2281780212 countsByYear W22817802122013 @default.
- W2281780212 countsByYear W22817802122014 @default.
- W2281780212 countsByYear W22817802122015 @default.
- W2281780212 countsByYear W22817802122016 @default.
- W2281780212 countsByYear W22817802122017 @default.
- W2281780212 crossrefType "journal-article" @default.
- W2281780212 hasAuthorship W2281780212A5003759585 @default.
- W2281780212 hasAuthorship W2281780212A5005320470 @default.
- W2281780212 hasAuthorship W2281780212A5006794153 @default.
- W2281780212 hasAuthorship W2281780212A5012989533 @default.
- W2281780212 hasAuthorship W2281780212A5034024641 @default.
- W2281780212 hasAuthorship W2281780212A5056078581 @default.
- W2281780212 hasAuthorship W2281780212A5060962854 @default.
- W2281780212 hasAuthorship W2281780212A5064287277 @default.
- W2281780212 hasAuthorship W2281780212A5067484188 @default.
- W2281780212 hasConcept C126322002 @default.
- W2281780212 hasConcept C16005928 @default.
- W2281780212 hasConcept C197934379 @default.
- W2281780212 hasConcept C2776256026 @default.
- W2281780212 hasConcept C2778570526 @default.
- W2281780212 hasConcept C2779802037 @default.
- W2281780212 hasConcept C2780580376 @default.
- W2281780212 hasConcept C71924100 @default.
- W2281780212 hasConcept C90924648 @default.
- W2281780212 hasConceptScore W2281780212C126322002 @default.
- W2281780212 hasConceptScore W2281780212C16005928 @default.
- W2281780212 hasConceptScore W2281780212C197934379 @default.
- W2281780212 hasConceptScore W2281780212C2776256026 @default.
- W2281780212 hasConceptScore W2281780212C2778570526 @default.
- W2281780212 hasConceptScore W2281780212C2779802037 @default.
- W2281780212 hasConceptScore W2281780212C2780580376 @default.
- W2281780212 hasConceptScore W2281780212C71924100 @default.
- W2281780212 hasConceptScore W2281780212C90924648 @default.
- W2281780212 hasIssue "8" @default.
- W2281780212 hasLocation W22817802121 @default.
- W2281780212 hasOpenAccess W2281780212 @default.
- W2281780212 hasPrimaryLocation W22817802121 @default.
- W2281780212 hasRelatedWork W1585348844 @default.
- W2281780212 hasRelatedWork W2041128529 @default.
- W2281780212 hasRelatedWork W2105212912 @default.
- W2281780212 hasRelatedWork W2320562621 @default.
- W2281780212 hasRelatedWork W2332114612 @default.
- W2281780212 hasRelatedWork W2350328551 @default.
- W2281780212 hasRelatedWork W2361331986 @default.
- W2281780212 hasRelatedWork W2379233625 @default.
- W2281780212 hasRelatedWork W2480155873 @default.
- W2281780212 hasRelatedWork W4214493149 @default.
- W2281780212 hasVolume "34" @default.
- W2281780212 isParatext "false" @default.
- W2281780212 isRetracted "false" @default.
- W2281780212 magId "2281780212" @default.
- W2281780212 workType "article" @default.